John T Curnutte Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John T Curnutte.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John T Curnutte. John T Curnutte is a Director in Diadexus, Inc. ($DDXS) and a EVP R&D in PORTOLA PHARMACEUTICALS INC ($PTLA) and an Executive Vice President in PORTOLA PHARMACEUTICALS INC ($PTLA) and a Interim Co-President & EVP R&D in PORTOLA PHARMACEUTICALS INC ($PTLA) and a Director in Orchard Therapeutics plc ($ORTX).
Address: C/O PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO 94080 CA
Companies in which John T Curnutte is an Insider
Diadexus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John T Curnutte: Director
Holdings: 0 shares
Latest Transaction: Jul 16 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Orchard Therapeutics plc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John T Curnutte: Director
Holdings: 0 shares
Latest Transaction: Jun 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PORTOLA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John T Curnutte: Interim Co-President & EVP R&D, Executive Vice President
Holdings: 103,227 shares
Current Value: $2,919,260
Latest Transaction: May 21 2019
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John T Curnutte
Sentiment: All, DDXS, ORTX, PTLA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2020 | ORTX | Orchard Therapeuti ... | Curnutte John T | Director | Option Exercise | A | 7.81 | 35,000 | 273,350 | 35,000 | |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Option Exercise | M | 0.00 | 4,688 | 0 | 0 | |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 28.69 | 903 | 25,907 | 101,656 | 102.6 K to 101.7 K (-0.88 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Payment of Exercise | F | 28.69 | 2,418 | 69,372 | 102,559 | 105 K to 102.6 K (-2.30 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 1,750 | 0 | 104,977 | 103.2 K to 105 K (+1.70 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Grant | A | 0.00 | 4,688 | 0 | 103,227 | 98.5 K to 103.2 K (+4.76 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Curnutte John T | EVP R&D | Option Exercise | A | 27.10 | 18,000 | 487,800 | 18,000 |